Glofitamab,Obinutuzumab,Tocilizumab
roche
['2000', 'obinu', 'glofitamab', 'lymsm']
congress | #ash22 of shares data on glofitamab monotherapy in patients with r/r #mcl. glofitamab was shown to induce high and durable cr rates with an acceptable safety profile. most crs events were manageable and of low-grade. #lymsm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm